Position in BLLN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,099,410
New position
Shares Held
17,498
first reported quarter
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 156 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $1,364,038,790 across 24 Diagnostics & Research names. BLLN ranks #21 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
2,079,578 | $276,230,345 | |
| 2 | ILMN |
Illumina, Inc.
|
907,489 | $159,563,790 | |
| 3 | NEO |
Neogenomics Inc
|
10,113,261 | $147,552,477 | |
| 4 | VCYT |
Veracyte, Inc.
|
2,507,902 | $147,289,084 | |
| 5 | NTRA |
Natera, Inc.
|
511,214 | $138,769,040 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
202,754 | $106,737,815 | |
| 7 | WAT |
Waters Corp /De/
|
272,470 | $102,187,148 | |
| 8 | DGX |
Quest Diagnostics Inc
|
290,970 | $61,671,091 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,099,410 | 17,498 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||